Preclinical biotech using metagenomics-derived genome editing.
Industry: Health Care
Latest Trade: $2.11 +0.01 (+0.2%)
First Day Return: -31.3%
Return from IPO: -86.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/05/2024 |
Offer Price | $15.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 6.3 |
Deal Size ($mm) | $94 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/08/2024 |
Offer Price | $15.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 6.3 |
Deal Size ($mm) | $94 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
J.P. Morgan |
Jefferies |
more |
Company Data | |
---|---|
Headquarters | Emeryville, CA, United States |
Founded | 2016 |
Employees at IPO | 223 |
Website www.metagenomi.co |